Precose and Tachycardia aggravated - a phase IV clinical study of FDA data

Summary:

Tachycardia aggravated is reported as a side effect among people who take Precose (acarbose), especially for people who are female, 10-19 old, also take Neurontin, and have Diabetes.

The phase IV clinical study analyzes which people have Tachycardia aggravated when taking Precose. It is created by eHealthMe based on reports of 1,186 people who have side effects when taking Precose from the FDA, and is updated regularly.

What is Precose?

Precose has active ingredients of acarbose. eHealthMe is studying from 1,189 Precose users. Check the latest studies of Precose.

What is Tachycardia aggravated?

Tachycardia aggravated (a heart rate that exceeds the normal range) is found to be associated with 3,015 drugs and 2,268 conditions by eHealthMe. Check the latest studies of Tachycardia aggravated.

On Jul, 31, 2026

1,186 people reported to have side effects when taking Precose.
Among them, 12 people (1.01%) have Tachycardia aggravated.

Could Precose cause Tachycardia aggravated?

Among these 12 people:

What is the gender of people who have Tachycardia aggravated when taking Precose? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Tachycardia aggravated when taking Precose? *

What are other drugs people take besides Precose? *

What are other side effects people have besides Tachycardia aggravated? *

Dyspnea (difficult or laboured breathing): 5 people, 41.67%
Nervousness: 3 people, 25.00%
Nausea And Vomiting: 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Cardiac Arrest: 3 people, 25.00%
Heart Attack: 3 people, 25.00%
Stress And Anxiety: 3 people, 25.00%
Blood Glucose Increased: 3 people, 25.00%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 16.67%
Constipation: 2 people, 16.67%

What are the existing conditions these people have? *

Diabetes: 3 people, 25.00%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 16.67%
Impaired Gastric Emptying: 2 people, 16.67%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 2 people, 16.67%
Back Pain: 2 people, 16.67%
Asthma: 2 people, 16.67%
Reactive Airways Dysfunction Syndrome (irritant-induced asthma): 1 person, 8.33%
Pain: 1 person, 8.33%
Muscle Spasms (muscle contraction): 1 person, 8.33%
Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Precose and have Tachycardia aggravated?

- Check whether Tachycardia aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Precose:

Precose (1,189 reports)

Browse all side effects of Precose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tachycardia aggravated:

Tachycardia aggravated (3,015 drugs)

Browse all the conditions that are associated with Tachycardia aggravated:

Tachycardia aggravated (2,268 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acarbose (the active ingredients of Precose) and Precose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.